|
Market Closed -
Nasdaq
16:00:00 2026-08-14 EDT
|
5-day change | 1st Jan Change | ||
| 505.75 USD | -2.07% |
|
+1.95% | +11.56% |
| 08-12 | Vertex Has Multiple Portfolio Catalysts With Favorable Risk-Reward, RBC Says | MT |
| 08-11 | Jefferies Adjusts Price Target on Vertex Pharmaceuticals to $633 From $610, Maintains Buy Rating | MT |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -2.07% | +1.95% | +4.06% | +15.75% | +11.56% | +28.76% | +47.27% | +164.83% | +405.75% | 128B | |
| -2.25% | -0.47% | +0.94% | +17.44% | +9.82% | +68.30% | +116.05% | +337.19% | +1,378.16% | 1,052B | |
| -0.66% | +0.43% | +4.15% | +14.84% | +25.80% | +47.39% | +51.02% | +46.40% | +116.36% | 627B | |
| -0.54% | +1.39% | -1.94% | +18.57% | +9.18% | +20.69% | +64.61% | +110.67% | +273.78% | 441B | |
| -1.99% | -3.32% | +7.09% | +10.01% | +8.20% | +38.71% | +36.26% | -3.60% | +44.70% | 349B | |
| -1.05% | -2.81% | -0.67% | +4.94% | +11.72% | +23.07% | +35.91% | +42.52% | +54.79% | 287B | |
| -2.12% | -3.67% | -9.25% | -15.93% | -16.90% | -1.14% | +5.35% | +35.19% | +124.84% | 241B | |
| -0.63% | +1.04% | +11.74% | +27.24% | +26.86% | +40.05% | +56.67% | +79.69% | +141.18% | 224B | |
| -1.19% | -3.41% | -12.24% | -1.50% | -9.39% | -9.57% | -53.50% | -9.17% | +90.25% | 202B | |
| +0.16% | +3.87% | +1.51% | +6.78% | +12.73% | +16.89% | +77.38% | +92.94% | +74.59% | 172B | |
| -0.04% | +0.11% | +6.56% | +5.76% | +7.59% | +6.56% | -24.49% | -45.23% | -23.00% | 153B | |
| -1.27% | -1.38% | +5.49% | +11.98% | +18.34% | +31.77% | +4.76% | -7.06% | +7.44% | 130B | |
| -1.19% | +0.28% | -1.85% | +2.11% | -8.70% | -11.10% | -21.60% | -14.23% | +6.56% | 105B | |
| -2.10% | -7.29% | -7.08% | -2.42% | -0.38% | +27.54% | +32.61% | -3.01% | -13.94% | 98.67B | |
| -0.72% | -3.22% | -6.03% | -12.71% | -16.50% | +9.95% | +61.16% | +69.16% | +494.22% | 71.68B | |
| -1.75% | -1.24% | +0.60% | +5.03% | +14.02% | +22.89% | +24.19% | +51.00% | +17.55% | 56.3B | |
| -0.56% | -4.06% | +0.15% | +26.73% | +29.13% | +76.71% | -6.29% | +0.07% | -51.19% | 54.36B | |
| -2.12% | -3.66% | -6.02% | -2.54% | -11.67% | -17.00% | +28.31% | -6.82% | +213.20% | 51.37B | |
| +0.68% | +3.99% | +14.12% | +7.23% | +17.81% | +105.88% | +290.34% | +277.52% | -31.64% | 42.85B | |
| -0.64% | -3.74% | -3.92% | +6.82% | -5.12% | -0.22% | +9.16% | - | - | 42.44B | |
| Average | -1.10% | -0.11% | +0.37% | +7.31% | +6.70% | +26.31% | +41.76% | +64.11% | +174.93% | 226.44B | |
| Weighted average by Cap. | -1.31% | -0.05% | +0.95% | +10.96% | +9.77% | +35.49% | +54.23% | +114.77% | +414.48% |
- Stock Market
- Stocks
- VRTX Stock
- Sector Vertex Pharmaceuticals Incorporated
Select your edition
All financial news and data tailored to specific country editions
